• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症饥饿疗法的现状。

Current status of cancer starvation therapy.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Apr 25;51(2):241-250. doi: 10.3724/zdxbyxb-2021-0297.

DOI:10.3724/zdxbyxb-2021-0297
PMID:35462463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10410570/
Abstract

Conventional therapies for malignant tumors have limitations and disadvantages. In recent years, the cancer starvation therapy has emerged which intends to deprive cancer cells of nutritional supply. There are several approaches to"starve" cancer cells: to intervene tumor angiogenesis by targeted inhibition of angiogenic factors or their receptors and integrins; to block the blood supply of cancer cells by embolizing or compressing blood vessels; to intervene metabolic process of cancer cells by inhibition of the signal pathways of mitochondrial serine-glycine-one earbon metabolism, glycolysis and amino acid metabolism; cancer starvation therapy can be employed with oxidation therapy, chemotherapy, sonodynamic therapy, anti-autophagy therapy or other therapies to achieve synergistic effects. This article reviews the research progress of cancer starvation therapy in recent years and discusses the existing problems.

摘要

恶性肿瘤的传统治疗方法存在局限性和缺点。近年来,出现了一种癌症饥饿疗法,旨在剥夺癌细胞的营养供应。有几种方法可以“饿死”癌细胞:通过靶向抑制血管生成因子或其受体和整合素来干预肿瘤血管生成;通过栓塞或压迫血管来阻断癌细胞的血液供应;通过抑制线粒体丝氨酸-甘氨酸-一碳代谢、糖酵解和氨基酸代谢信号通路来干预癌细胞的代谢过程;癌症饥饿疗法可以与氧化疗法、化疗、声动力学疗法、抗自噬疗法或其他疗法联合使用,以达到协同作用。本文综述了近年来癌症饥饿疗法的研究进展,并讨论了存在的问题。

相似文献

1
Current status of cancer starvation therapy.癌症饥饿疗法的现状。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Apr 25;51(2):241-250. doi: 10.3724/zdxbyxb-2021-0297.
2
Metabolic effects of anti-angiogenic therapy in tumors.肿瘤抗血管生成治疗的代谢效应。
Biochimie. 2012 Apr;94(4):925-31. doi: 10.1016/j.biochi.2012.01.001. Epub 2012 Jan 11.
3
Anti-Angiogenics: Current Situation and Future Perspectives.抗血管生成药物:现状与未来展望。
Oncol Res Treat. 2018;41(4):166-171. doi: 10.1159/000488087. Epub 2018 Mar 23.
4
Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.逃避肿瘤的逃避:抗血管生成癌症治疗的当前概念和观点。
Drug Resist Updat. 2010 Feb-Apr;13(1-2):16-28. doi: 10.1016/j.drup.2009.12.001. Epub 2010 Jan 12.
5
Broad targeting of angiogenesis for cancer prevention and therapy.针对癌症预防和治疗的广泛血管生成靶向作用。
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16.
6
Targeted therapies of cancer: angiogenesis inhibition seems not enough.癌症的靶向治疗:血管生成抑制似乎还不够。
Cancer Lett. 2010 Dec 18;299(1):1-10. doi: 10.1016/j.canlet.2010.09.004.
7
Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.肿瘤血管生成的分子调控:机制与治疗意义
EXS. 2006(96):223-68. doi: 10.1007/3-7643-7378-4_10.
8
Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.肿瘤血管生成:条条大路通罗马——对血管生成靶向癌症治疗的启示。
Mol Aspects Med. 2011 Apr;32(2):71-87. doi: 10.1016/j.mam.2011.04.001. Epub 2011 Apr 22.
9
Clinical approaches toward tumor angiogenesis: past, present and future.肿瘤血管生成的临床治疗方法:过去、现在与未来
Curr Pharm Des. 2008;14(36):3820-34. doi: 10.2174/138161208786898680.
10
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.癌症治疗中针对血管生成:超越血管内皮生长因子
Oncologist. 2015 Jun;20(6):660-73. doi: 10.1634/theoncologist.2014-0465. Epub 2015 May 22.

引用本文的文献

1
GDF15 promotes gallbladder cancer progression by activating the NF-κB mediated Vascular Endothelial Growth Factor A (VEGFA) expression.生长分化因子15通过激活核因子κB介导的血管内皮生长因子A(VEGFA)表达促进胆囊癌进展。
Am J Cancer Res. 2025 Jun 25;15(6):2779-2793. doi: 10.62347/NAZM2261. eCollection 2025.
2
Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment.稳定三角:基于纳米医学的光疗和免疫疗法协同应用于肿瘤治疗。
J Nanobiotechnology. 2024 Oct 18;22(1):635. doi: 10.1186/s12951-024-02925-3.
3
Advances in multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer starvation therapy.多功能金属有机骨架(MOF)基纳米平台在癌症饥饿治疗中的研究进展。
Expert Rev Mol Med. 2024 Oct 14;26:e27. doi: 10.1017/erm.2024.28.
4
Platinum Group Metals Nanoparticles in Breast Cancer Therapy.铂族金属纳米颗粒在乳腺癌治疗中的应用
Pharmaceutics. 2024 Sep 3;16(9):1162. doi: 10.3390/pharmaceutics16091162.
5
Recent advances in glucose oxidase-based nanocarriers for tumor targeting therapy.用于肿瘤靶向治疗的基于葡萄糖氧化酶的纳米载体的最新进展。
Heliyon. 2023 Sep 25;9(10):e20407. doi: 10.1016/j.heliyon.2023.e20407. eCollection 2023 Oct.
6
Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review.使用叶酸偶联的海绵状ZIF-8纳米颗粒的靶向癌症治疗:综述
Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1377-1404. doi: 10.1007/s00210-023-02707-y. Epub 2023 Sep 16.

本文引用的文献

1
Emerging therapeutic opportunities for integrin inhibitors.整合素抑制剂的新兴治疗机会。
Nat Rev Drug Discov. 2022 Jan;21(1):60-78. doi: 10.1038/s41573-021-00284-4. Epub 2021 Sep 17.
2
Chronic exposure to FGF2 converts iPSCs into cancer stem cells with an enhanced integrin/focal adhesion/PI3K/AKT axis.长期暴露于成纤维细胞生长因子2(FGF2)会将诱导多能干细胞(iPSCs)转化为癌症干细胞,同时增强整合素/粘着斑/磷脂酰肌醇-3-激酶(PI3K)/蛋白激酶B(AKT)信号轴。
Cancer Lett. 2021 Aug 26;521:142-154. doi: 10.1016/j.canlet.2021.08.026.
3
Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.RBM-007,一种抗 FGF2 适体的多种治疗应用。
Cells. 2021 Jun 28;10(7):1617. doi: 10.3390/cells10071617.
4
Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy.仿生纳米反应器用于靶向癌症饥饿治疗和级联放大化疗。
Biomaterials. 2021 Jul;274:120869. doi: 10.1016/j.biomaterials.2021.120869. Epub 2021 May 7.
5
lncRNA has potential to be a predictive marker for pazopanib therapy in patients with sarcoma.长链非编码RNA有潜力成为肉瘤患者帕唑帕尼治疗的预测标志物。
Oncol Lett. 2021 Jun;21(6):455. doi: 10.3892/ol.2021.12716. Epub 2021 Apr 8.
6
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.长链非编码 RNA-NEAT1 的抑制通过去抑制 microRNA-34a/LDHA 轴使 5-Fu 耐药宫颈癌细胞敏感。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20200533.
7
Targeting the Proline-Glutamine-Asparagine-Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy.在氨基酸饥饿癌症治疗中靶向脯氨酸-谷氨酰胺-天冬酰胺-精氨酸代谢轴
Pharmaceuticals (Basel). 2021 Jan 18;14(1):72. doi: 10.3390/ph14010072.
8
Reversible Bevacizumab Induced Vocal Fold Necrosis.贝伐单抗诱导的可逆性声带坏死。
J Voice. 2023 Mar;37(2):257-259. doi: 10.1016/j.jvoice.2020.11.028. Epub 2021 Jan 7.
9
Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.乳酸和酸性肿瘤微环境抑制抗肿瘤免疫。
Int J Mol Sci. 2020 Nov 7;21(21):8363. doi: 10.3390/ijms21218363.
10
Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis.Talin 依赖性整合素激活对于血管内皮细胞增殖和出生后血管生成是必需的。
Angiogenesis. 2021 Feb;24(1):177-190. doi: 10.1007/s10456-020-09756-4. Epub 2020 Oct 28.